Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa

Abstract

Artesunate is a highly cost-effective and affordable alternative to quinine for treating children with severe malaria. The budgetary implications of adopting artesunate for routine use in hospital-based care are negligible.